Leukemia, 0887-6924

Journal

1 - 20 out of 64Page size: 20

Publications

  1. Published

    Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia

    & 2 others, Dickens Pratt, 1 Apr 2010, In: Leukemia. 24, 4, p. 877-881 5 p.

    Research output: Contribution to journal › Article

  2. Published

    A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL

    Anna Skowronska, Tatjana Stankovic, 1 Jul 2008, In: Leukemia. 22, 7, p. 1456-1459 4 p.

    Research output: Contribution to journal › Article

  3. Published

    Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors

    Charlotte Bradbury, Farhat Khanim, McNeill Hayden, Christopher Bunce, Darren White, Mark Drayson, Charles Craddock & Bryan Turner, 25 Aug 2005, In: Leukemia. 19, 10, p. 1751-1759 9 p.

    Research output: Contribution to journal › Article

  4. Published

    Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemia

    Aimee Jackson, Josephine Khan, Naeem Khan, Charles Craddock & Sylvie Freeman, Apr 2015, In: Leukemia. 29, p. 988-991

    Research output: Contribution to journal › Article › peer-review

  5. Published

    Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage

    Victoria Weston, Tatjana Stankovic, 1 Apr 2012, In: Leukemia. 26, 4, p. 826-830 5 p.

    Research output: Contribution to journal › Article

  6. Published

    Indomethacin potentiates the induction of HL60 differentiation to neutrophils, by retinoic acid and granulocyte colony-stimulating factor, and to monocytes, by vitamin D3

    Christopher Bunce & Geoff Brown, 1 Jan 1994, In: Leukemia. 8, 4, p. 595-604 10 p.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: Results from the LRF AML14 and NCRI AML16 pick-a-winner comparison

    Robert Hills, Keith Wheatley, 1 Jan 2013, In: Leukemia. 27, 1, p. 75-81 7 p.

    Research output: Contribution to journal › Article › peer-review

  8. Published

    The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome

    Keith Wheatley, 1 Jul 2011, In: Leukemia. 25, 7, p. 1122-1127 6 p.

    Research output: Contribution to journal › Article

  9. Published

    A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

    Sylvie Freeman, 31 Dec 2018, In: Leukemia. 5 p.

    Research output: Contribution to journal › Article › peer-review

  10. E-pub ahead of print

    A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia

    Robert Hills, Sylvie Freeman, 30 Sep 2016, (E-pub ahead of print) In: Leukemia.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells

    Marwan Cheng Kuang Kwok, Nov 2005, In: Leukemia. 19, p. 1896-1904

    Research output: Contribution to journal › Article › peer-review

  12. Published

    Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party

    Keith Wheatley, 2 May 2002, In: Leukemia. 16, 5, p. 776-784 9 p.

    Research output: Contribution to journal › Article

  13. Published

    IMWG consensus on risk stratification in multiple myeloma

    Keith Wheatley, Feb 2014, In: Leukemia. 28, 2, p. 269-77 9 p.

    Research output: Contribution to journal › Article › peer-review

  14. Published

    MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia

    Stephanie Dumon, Sylvie Freeman, Ban Dawood, Lozan Sheriff, Maelle Lorvellec, Jon Frampton & Paloma Garcia, 2012, In: Leukemia. 27, 3, p. 661-670 10 p.

    Research output: Contribution to journal › Article › peer-review

  15. E-pub ahead of print

    Transcriptional regulation of SPROUTY 2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3

    Mary Clarke, Giacomo Volpe, Lozan Sheriff, Carl Ward, Wenbin Wei, Stephanie Dumon, Paloma Garcia & Jon Frampton, 8 Nov 2016, (E-pub ahead of print) In: Leukemia.

    Research output: Contribution to journal › Article › peer-review

  16. Published

    Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia.

    Charles Craddock, 1 May 2011, In: Leukemia. 25, 5, p. 808-13 6 p.

    Research output: Contribution to journal › Article

  17. Published

    Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia

    Charles Craddock, Sylvie Freeman, Manoj Raghavan, Robert Hills, Toon Brookes, Mark Griffiths & 5 others, , 2012, In: Leukemia. 27, 5, p. 1028-1036 9 p.

    Research output: Contribution to journal › Article › peer-review

  18. Published

    International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

    Sudhesh Kumar & Keith Wheatley, Sep 2009, In: Leukemia. 23, 9, p. 1545-56 12 p.

    Research output: Contribution to journal › Article › peer-review

  19. Published

    International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    & 15 others, & Keith Wheatley, Feb 2009, In: Leukemia. 23, 2, p. 215-24 10 p.

    Research output: Contribution to journal › Article › peer-review

  20. Published

    A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia

    Pierre Cauchy, Peter Cockerill, Jul 2014, In: Leukemia. 28, 7, p. 1570-1572 3 p.

    Research output: Contribution to journal › Letter › peer-review

Previous 1 2 3 4 Next